Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,526 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy.
CAT-152 0102 Trabeculectomy Study Group, Khaw P, Grehn F, Holló G, Overton B, Wilson R, Vogel R, Smith Z. CAT-152 0102 Trabeculectomy Study Group, et al. Among authors: vogel r. Ophthalmology. 2007 Oct;114(10):1822-30. doi: 10.1016/j.ophtha.2007.03.050. Ophthalmology. 2007. PMID: 17908591 Clinical Trial.
Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain.
Korenfeld MS, Silverstein SM, Cooke DL, Vogel R, Crockett RS; Difluprednate Ophthalmic Emulsion 0.05% (Durezol) Study Group. Korenfeld MS, et al. Among authors: vogel r. J Cataract Refract Surg. 2009 Jan;35(1):26-34. doi: 10.1016/j.jcrs.2008.09.024. J Cataract Refract Surg. 2009. PMID: 19101421 Clinical Trial.
An immunogenic model of KRAS-mutant lung cancer enables evaluation of targeted therapy and immunotherapy combinations.
Boumelha J, de Carné Trécesson S, Law EK, Romero-Clavijo P, Coelho M, Ng K, Mugarza E, Moore C, Rana S, Caswell DR, Murillo M, Hancock DC, Argyris PP, Brown WL, Durfee C, Larson LK, Vogel RI, Suarez-Bonnet A, Priestnall SL, East P, Ross SJ, Kassiotis G, Molina-Arcas M, Swanton C, Harris R, Downward J. Boumelha J, et al. Among authors: vogel ri. Cancer Res. 2022 Aug 5:CAN-22-0325. doi: 10.1158/0008-5472.CAN-22-0325. Online ahead of print. Cancer Res. 2022. PMID: 35930804
1,526 results